The Rutgers Brain Health Institute announced the recipients of the Fall 2026 Trainee Travel Awards, which recognize ...

The Society for Neuroscience (SfN) will honor four pioneering researchers whose innovative work has transformed the understanding of the nervous system with this year’s Outstanding Career and Research ...

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel ...

Pharmaceutical company AbbVie (NYSE:ABBV) in Q3 2026, with sales up 10.3% year on year to $17.4 billion. Its non-GAAP profit ...

Aspen Neuroscience is pursuing a $150 million IPO to fund Parkinson’s disease stem cell therapies. Click here to read an ...

The brain is unbelievably complicated, which is both daunting and fascinating for neuroscientists like me. In the space of a cubic millimeter – about the size of a single poppy seed – there are tens ...

Explore the fascinating world of neuroscience by learning about the basic structure, communication, and classification of ...

Imagine a world where Alzheimer’s is reversible, paralysis is no longer permanent and treatments for improving mental health are universally available and applied. A world where we have fully explored ...

The shares are expected to begin trading on The Nasdaq Global Select Market on October 30, 2026, under the ticker symbol “ASPE.” The offering is expected to close on November 2, 2026, subject to the ...

Why do some people seem better able to navigate life's challenges? Can meditation and mindfulness actually change the brain? And what does neuroscience tell us about finding greater meaning, ...

Aspen Neuroscience priced at $15 a share, raising about $140.6 million for its cell therapy work in Parkinson's disease.